Subscribe for the latest consumer trends, trade news, nutrition science and regulatory updates in the supplement industry!
Join 37,000+ members. Yes, it's completely free.
FDA Accepts ADMs Flax Concentrate
March 12, 2007
1 Min Read
DECATUR, Ill.—The Food and Drug Administration (FDA) had no concerns following a compulsory 75-day notification period for ADM’s new Beneflax™ flax lignan concentrate, allowing the product to be offered for general sale. “Research shows that flax lignans have many potential health benefits, and Beneflax offers the highest concentration of flax lignan complex available today,” said Janice Binger, president, ADM Natural Health and Nutrition (www.admworld.com).
You May Also Like